US drug approvals
21 approvals with a product on the US market
- Evoxac NDA221183 · approved 15 Oct 2026
- Vyleesi (Autoinjector) NDA210557 · approved 21 Jun 2019
- Sympazan NDA210833 · approved 1 Nov 2018
- Nystatin ANDA209114 · approved 6 Oct 2017
- Tribenzor NDA200175 · approved 23 Jul 2010
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.